ID   Y6
AC   CVCL_5F74
SY   Y-6
DR   Wikidata; Q54995193
RX   PubMed=4311571;
RX   PubMed=6270152;
RX   PubMed=7588376;
RX   PubMed=15541570;
CC   Doubling time: 76.8 hours (PubMed=4311571).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0585 ! Y1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
RX   PubMed=4311571; DOI=10.1002/jcp.1040740203;
RA   Schimmer B.P.;
RT   "Phenotypically variant adrenal tumor cell cultures with biochemical
RT   lesions in the ACTH-stimulated steroidogenic pathway.";
RL   J. Cell. Physiol. 74:115-122(1969).
//
RX   PubMed=6270152; DOI=10.1016/S0021-9258(19)68600-X;
RA   Watt V.M., Schimmer B.P.;
RT   "Association of a 68,000-dalton protein with adrenocorticotropin-sensitive
RT   adenylate cyclase activity in Y1 adrenocortical tumor cells.";
RL   J. Biol. Chem. 256:11365-11371(1981).
//
RX   PubMed=7588376; DOI=10.3109/07435809509030430;
RA   Schimmer B.P., Kwan W.K., Tsao J., Qiu R.;
RT   "ACTH-receptor deficient mutants of the Y1 mouse adrenocortical tumor
RT   cell line.";
RL   Endocr. Res. 21:139-156(1995).
//
RX   PubMed=15541570; DOI=10.1016/j.mce.2003.12.020;
RA   Rainey W.E., Saner K., Schimmer B.P.;
RT   "Adrenocortical cell lines.";
RL   Mol. Cell. Endocrinol. 228:23-38(2004).
//